Exosomal microRNAs from Longitudinal Liquid Biopsies for the Prediction of Response to Induction Chemotherapy in HR-NBL Patients
Previous
Previous
Anti-GD2 antibodies in treatment of high-risk Neuroblastoma: present and perspectives
Next
Next